
Tom Fitton @TomFitton
"Protection against infection from the omicron variant of the coronavirus was low. For children ages 6 months to 2 years, efficacy was 43.7 percent, and in children ages 2 to 6, it was only 37.5 percent." — PolitiTweet.org
MSNBC @MSNBC
Moderna says its Covid-19 vaccine generates a strong immune response and is generally well-tolerated in kids ages 6… https://t.co/G8F0bpIW9L